MCM
MEDP icon

Maryland Capital Management’s Medpace MEDP Stock Holding History

Maryland Capital Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$367K Buy
2,334
+165
+8% +$26.3K 0.03% 168
2022
Q2 		$325K Buy
2,169
+917
+73% +$133K 0.03% 185
2022
Q1 		$205K Buy
+1,252
New +$206K 0.01% 239

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
ESCM
Echo Street Capital Management New York $747M AUM 24.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Maryland Capital Management's MEDP Position: Q3 2022 in Review

Maryland Capital Management increased its Medpace (MEDP) stake by 7.6% in Q3 2022, buying an estimated $26.3K and bringing the position to 2,334 shares worth $367K. The position accounts for 0.03% of the portfolio, ranked #168.

Maryland Capital Management first reported a position in MEDP in Q1 2022 and has held it in 3 quarters since. 357 funds tracked by Wall St. Rank hold MEDP as of Q3 2022.

  • Maryland Capital Management held 2,334 shares of Medpace worth $367K as of Q3 2022.
  • Maryland Capital Management bought 165 Medpace shares in Q3 2022, an estimated $26.3K.
  • Medpace made up 0.03% of Maryland Capital Management's portfolio in Q3 2022, its #168 holding.
  • Maryland Capital Management first reported a position in Medpace in Q1 2022 and has held it in 3 quarters since.
  • 357 funds tracked by Wall St. Rank held Medpace as of Q3 2022.

Based on Maryland Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.